Pleuropulmonary pathology in patients with rheumatic disease

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 10, 2012, Pages 1242-1252

  Schneider, Frank ^a   Gruden, James ^b   Tazelaar, Henry D ^b   Leslie, Kevin O ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; HUMAN; LUNG DISEASE; PLEURA DISEASE; REVIEW; RHEUMATIC DISEASE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG DISEASES; PLEURAL DISEASES; RHEUMATIC DISEASES;

EID: 84868311050     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0248-SA     Document Type: Conference Paper

References (126)

1. Black L, Katz, S. Respiratory Disease: Task Force Report on Problems, Research Approaches, Needs. Arlington, VA: National Heart and Lung Institute; 1977. DHEW report NIH77-1248.
2. Colby TV. Pulmonary pathology in patients with systemic autoimmune diseases. Clin Chest Med. 1998;19(4):587-612, vii.
3. Douglas W, Tazelaar H, Hartman T, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164(7): 1182-1185.
4. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011;140(5):1292-1299.
5. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest. 2010; 138(2):251-256.
6. Schneider F, Tazelaar HD. The lung and systemic disease: a practical approach for the surgical pathologist. Pathologica. 2010;102(6):506-524.
7. Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 1999;23(6):941-948.
8. Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004;232(1):81-91.
9. White ES, Tazelaar HD, Lynch JP, III. Bronchiolar complications of connective tissue diseases. Semin Respir Crit Care Med. 2003;24(5):543-566.
10. Lee H-K, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005; 127(6):2019-2027.
11. Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994;193(2):375-382.
12. Yousem S, Colby T, Carrington C. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis. 1985;131(5):770-777.
13. Lamblin C, Bergoin C, Saelens T, Wallaert B. Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl. 2001;32:69S-80S.
14. Yoshinouchi T, Ohtsuki Y, Fujita J, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int. 2005;26(2):121-125.
15. Hakala M, Paakko P, Huhti E, Tarkka M, Sutinen S. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol. 1990;9(4):452-460.
16. Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004;44(6):585-596.
17. Katzenstein A, Fiorelli R. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol. 1994;18(2):136- 147.
18. Devouassoux G, Cottin V, Lioté H, et al; Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J. 2009;33(5): 1053-1061.
19. Schwarz MI, Zamora MR, Hodges TN, Chan ED, Bowler RP, Tuder RM. Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest. 1998;113(6):1609-1615.
20. Rice AJ, Wells AU, Bouros D, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am J Clin Pathol. 2003; 119(5):709-714.
21. Song JW, Do K-H, Kim M-Y, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009;136(1):23-30.
22. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis. 1985;131(5):770-777.
23. Atkins SR, Turesson C, Myers JL, et al. Morphologic and quantitative assessment of CD20 B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthritis Rheum. 2006;54(2):635-641.
24. Kim EJ, Collard HR, King TE Jr. Rheumatoid arthritis-associated interstitial lung disease. The relevance of histopathologic and radiographic pattern. Chest. 2009;136(5):1397-1405.
25. Park JH, Kim DS, Park I-N, et al. Prognosis of fibrotic interstitial pneumonia. Idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175(7):705-711.
26. Hubbard R, Venn A. The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. Rheumatology. 2002;41(6):676- 679.
27. Saag KG, Kolluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease: determinants of radiographic and physiologic abnormalities. Arthritis Rheum. 1996;39(10):1711-1719.
28. Kim EA, Johkoh T, Lee KS, et al. Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation. J Comput Assist Tomogr. 2001;25(5):757-763.
29. Cozzi F, Chiesura-Corona M, Rizzi M, et al. Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities. [in Italian]. Reumatismo. 2001;53(1):55-62.
30. Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004;232(2):560-567.
31. Zisman DA, Karlamangla AS, Ross DJ, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2007;132(3):773-779.
32. Pandey AK, Wilcox P, Mayo JR, et al. Predictors of pulmonary hypertension on high-resolution computed tomography of the chest in systemic sclerosis: a retrospective analysis. Can Assoc Radiol J. 2010;61(5):291-296.
33. Bhalla M, Silver RM, Shepard JA, McLoud TC. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol. 1993;161(2):269-272.
34. Kim DS, Yoo B, Lee JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(2):121-127.
35. Fujita J, Tokuda M, Bandoh S, et al. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol Int. 2001;20(2):81-84.
36. de Souza R, Borges C, Capelozzi V, et al. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis. Respiration. 2009;77(4):389-397.
37. Johnson DA, Drane WE, Curran J, et al. Pulmonary disease in progressive systemic sclerosis: a complication of gastroesophageal reflux and occult aspiration? Arch Intern Med. 1989;149(3):589-593.
38. Montesi A, Pesaresi A, Cavalli ML, Ripa G, Candela M, Gabrielli A. Oropharyngeal and esophageal function in scleroderma. Dysphagia. 1991;6(4): 219-223.
39. Yousem SA. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol. 1990;21(5):467-474.
40. Launay D, Mouthon J, Hachulla E, et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol. 2007;34(5):1005-1011.
41. Bridges AJ, Hsu KC, Dias-Arias AA, Chechani V. Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol. 1992;19(7):1136-1140.
42. Muir TE, Tazelaar HD, Colby TV, Myers JL. Organizing diffuse alveolar damage associated with progressive systemic sclerosis. Mayo Clin Proc. 1997; 72(7):639-642.
43. Griffin MT, Robb JD, Martin JR. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis. Thorax. 1990;45(11):903-904.
44. Bankier AA, Kiener HP, Wiesmayr MN, et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology. 1995;196(3):835- 840.
45. Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol. 1996;166(2):301-307.
46. Sant SM, Doran M, Fenelon HM, Breatnach ES. Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol. 1997;15(5):507-513.
47. Ooi GC, Ngan H, Peh WC, Mok MY, Ip M. Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clin Radiol. 1997;52(10): 775-781.
48. Cheema GS, Quismorio FP Jr. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med. 2000;6(5):424-429.
49. Oki H, Aoki T, Saito K, et al. Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome [published online ahead of print April 17, 2011]. Eur J Radiol. 2012;81(6):1335-1339.
50. Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore). 1975;54(5):397-409.
51. Susanto I, Peters JI. Acute lupus pneumonitis with normal chest radiograph. Chest. 1997;111(6):1781-1783.
52. Gruden JF, Webb WR, Warnock M. Centrilobular opacities in the lung on high-resolution CT: diagnostic considerations and pathologic correlation. AJR Am J Roentgenol. 1994;162(3):569-574.
53. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients. Am J Med. 1981;71(5):791-798.
54. Myers JL, Katzenstein AA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol. 1986;85(5):552-556.
55. Pope J. An update in pulmonary hypertension in systemic lupus erythematosus-do we need to know about it? Lupus. 2008;17(4):274-277.
56. Johnson SR, Granton JT. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur Respir Rev. Dec 2011;20(122):277-286.
57. Wakaki K, Koizumi F, Fukase M. Vascular lesions in systemic lupus erythematosus (SLE) with pulmonary hypertension. Acta Pathol Jpn. 1984;34(3): 593-604.
58. Asherson RA, Hackett D, Gharavi AE, Harris EN, Kennedy HG, Hughes GR. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases. J Rheumatol. 1986;13(2):416-420.
59. Yokoi T, Tomita Y, Fukaya M, Ichihara S, Kakudo K, Takahashi Y. Pulmonary hypertension associated with systemic lupus erythematosus: predominantly thrombotic arteriopathy accompanied by plexiform lesions. Arch Pathol Lab Med. 1998;122(5):467-470.
60. Roncoroni AJ, Alvarez C, Molinas F. Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus. Respiration. 1992; 59(1):52-56.
61. Asherson RA, Oakley CM. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol. 1986;13(1):1-5.
62. Fayemi AO. The lung in systemic lupus erythematosus: a clinicopathologic study of 20 cases. Mt Sinai J Med. 1975;42(2):110-118.
63. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997;76(3):192-202.
64. Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest. 2000; 118(4):1083-1090.
65. Min J, Hong Y, Park S, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol. 1997;24(11):2254-2257.
66. Gammon R, Bridges T, al-Nezir H, Alexander CB, Kennedy JI Jr. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest. 1992;102(4):1171-1174.
67. Filipek MS, Thompson ME, Wang PL, Gosselin MV. S LP. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus: radiographic and high-resolution CT findings. J Thorac Imaging. 2004;19(3): 200-203.
68. Eisenberg H, Dubois E, Sherwin R, Balchum O. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med. 1973;79(1):37-45.
69. Koh WH, Boey ML. Open lung biopsy in systemic lupus erythematosus patients with pulmonary disease. Ann Acad Med Singapore. 1993;22(3):323- 325.
70. Benisch B, Peison B. The association of lymphocytic interstitial pneumonia and systemic lupus erythematosus. Mt Sinai J Med. 1979;46(4):398-341.
71. Yood R, Steigman D, Gill L. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus. 1995;4(2):161-163.
72. Marenco JL, Sanchez-Burson J. Ruiz Campos J, Jimenez MD, Garcia- Bragado F. Pulmonary amyloidosis and unusual lung involvement in SLE. Clin Rheumatol. 1994;13(3):525-527.
73. Hariri LP, Unizony S, Stone J, et al. Acute fibrinous and organizing pneumonia in systemic lupus erythematosus: a case report and review of the literature. Pathol Int. 2010;60(11):755-759.
74. Ikezoe J, Johkoh T, Kohno N, Takeuchi N, Ichikado K, Nakamura H. Highresolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging. 1996;11(4):250-259.
75. Arakawa H, Yamada H, Kurihara Y, et al. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial highresolution CT findings and functional correlation. Chest. 2003;123(4):1096- 1103.
76. Mino M, Noma S, Taguchi Y, Tomii K, Kohri Y, Oida K. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol. 1997;169(1):83-87.
77. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990;141(3):727-733.
78. Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus. 2005;14(7):534-542.
79. Fujisawa T, Suda T, Nakamura Y, et al. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol. 2005;32(1):58-64.
80. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, et al; Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J. 2003;22(2):245-250.
81. Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 2002;47(6):614-622.
82. Ito M, Kaise S, Suzuki S, et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol. 1999;18(6):462-467.
83. Fata F, Rathore R, Schiff C, Herzlich BC. Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis. South Med J. 1997;90(2):227-230.
84. Hsue YT, Paulus HE, Coulson WF. Bronchiolitis obliterans organizing pneumonia in polymyositis: a case report with longterm survival. J Rheumatol. 1993;20(5):877-879.
85. Labirua A, Lundberg IE. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol. 2010; 22(6):633-638.
86. Yousem SA, Gibson K, Kaminski N, Oddis CV, Ascherman DP. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Mod Pathol. 2010;23(6):874-880.
87. Lee CS, Chen TL, Tzen CY, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol. 2002;21(5):391-396.
88. Mukae H, Ishimoto H, Sakamoto N, et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest. 2009;136(5):1341-1347.
89. Bonnefoy O, Ferretti G, Calaque O, et al. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol. 2004;49(3):235-244.
90. Schwarz MI, Sutarik JM, Nick JA, Leff JA, Emlen JW, Tuder RM. Pulmonary capillaritis and diffuse alveolar hemorrhage: a primary manifestation of polymyositis. Am J Respir Crit Care Med. 1995;151(6):2037-2040.
91. Bunch TW, Tancredi RG, Lie JT. Pulmonary hypertension in polymyositis. Chest. 1981;79(1):105-107.
92. Aisa Y, Yokomori H, Kashiwagi K, et al. Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection. Intern Med. 2001;40(11):1109-1112.
93. Marie I, Lahaxe L, Benveniste O, et al. Long-term outcome of patients with polymyositis/dermatomyositis and anti-PM-Scl antibody. Br J Dermatol. 2010;162(2):337-344.
94. Castaneda-Pomeda M, Prieto-Gonzalez S, Grau JM. Antisynthetase syndrome and malignancy: our experience. J Clin Rheumatol. 2011;17(8):458.
95. Meyer CA, Pina JS, Taillon D, Godwin JD. Inspiratory and expiratory highresolution CT findings in a patient with Sjögren's syndrome and cystic lung disease. AJR Am J Roentgenol. 1997;168(1):101-103.
96. Comment on J Clin Rheumatol. 2008;14(5): 285-288.
97. J Clin Rheumatol. 2009;15(5):254-255].
98. Franquet T, Gimenez A, Monill JM, Diaz C, Geli C. Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol. 1997;169(3):655-658.
99. Koyama M, Johkoh T, Honda O, et al. Pulmonary involvement in primary Sjögren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging. 2001;16(4):290-296.
100. Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282-289.
101. Watanabe M, Naniwa T, Hara M, Arakawa T, Maeda T. Pulmonary manifestations in Sjögren's syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol. 2010;37(2):365-373.
102. Lohrmann C, Uhl M, Warnatz K, et al. High-resolution CT imaging of the lung for patients with primary Sjögren's syndrome. Eur J Radiol. 2004;52(2):137- 143.
103. Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjögren's syndrome. Mayo Clin Proc. 1989;64(8):920-931.
104. Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632-638.
105. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest. 2006;130(5):1489-1495.
106. Kassan S, Thomas T, Moutsopoulos H, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978;89(6):888-892.
107. Jeong YJ, Lee KS, Chung MP, et al. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr. 2004;28(6):776-781.
108. Lee IJ, Kim SH, Koo SH, et al. Bronchus-associated lymphoid tissue (BALT) lymphoma of the lung showing mosaic pattern of inhomogeneous attenuation on thin-section CT: a case report. Korean J Radiol. 2000;1(3):159- 161.
109. Nakamura N, Yamada G, Itoh T, et al. Pulmonary MALT lymphoma with amyloid production in a patient with primary Sjögren's syndrome. Intern Med. 2002;41(4):309-311.
110. Takabatake N, Sayama T, Shida K, Matsuda M, Nakamura H, Tomoike H. Lung adenocarcinoma in lymphocytic interstitial pneumonitis associated with primary Sjögren's syndrome. Respirology. 1999;4(2):181-184.
111. Mosca M, Tani C, Carli L, Bombardieri S, Undifferentiated CTD: a wide spectrum of autoimmune diseases. Best Pract Res Clin Rheumatol. 2012;26(1): 73-77.
112. Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G. Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol. 1998; 17(3):195-201.
113. Sharp G, Irvin W, Tan E, Gould R, Holman H. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2): 148-159.
114. Cappelli S. Bellando Randone S, Martinovic D, et al. "To be or not to be, " ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012;41(4):589-598.
115. Cervera R, Khamashta MA, Hughes GR. 'Overlap' syndromes. Ann Rheum Dis. 1990;49(11):947-948.
116. Prakash UBS. Respiratory complications in mixed connective tissue disease. Clin Chest Med. 1998;19(4):733-746.
117. Hant FN, Herpel LB, Silver RM. Pulmonary manifestations of scleroderma and mixed connective tissue disease. Clin Chest Med. 2010;31(3):433-449.
118. Caramaschi P, Biasi D, Volpe A, Carletto A, Cecchetto M, Bambara LM. Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int. 2007;27(4):407-410.
119. Sacnun MP, Ferrer J, Ferrer M, Pons-Estel BA. Rapidly progressive fatal interstitial lung disease in a patient with an overlap syndrome of systemic lupus erythematosus and systemic sclerosis. Reumatol Clin. 2011;7(1):61-67.
120. Lin HK, Wang JD, Fu LS. Juvenile diffuse systemic sclerosis/systemic lupus erythematosus overlap syndrome-a case report [published online ahead or print May 1, 2011]. Rheumatol Int. 2012;32(6):1809-1811.
121. Luzi G, Diamanti AP, Germano V, et al. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis. Clin Immunol. 2007; 125(2):127-130.
122. Singh R, Huang W, Menon Y, Espinoza LR. Shrinking lung syndrome in systemic lupus erythematosus and Sj ögren's syndrome. J Clin Rheumatol. 2002; 8(6):340-345.
123. Weng CT, Cheng L, Wang CR. Pulmonary infarctions due to bilateral pulmonary arterial thrombosis in a lupus patient with antiphospholipid syndrome. J Rheumatol. 2008;35(10):2064-2065.
124. Prashanth P, Mukhaini MK. Primary antiphospholipid syndrome with recurrent coronary thrombosis, acute pulmonary thromboembolism and intracerebral hematoma. J Invasive Cardiol. 2009;21(12):E254-E258.
125. Hashimoto A, Endo H, Kondo H, Hirohata S. Clinical features of 405 Japanese patients with systemic sclerosis. Mod Rheumatol. 2012;22(2):272-279.
126. Fukuoka J, Leslie KO. Lung infections. In: Leslie KO, Wick MR, eds. Practical Pulmonary Pathology: A Diagnostic Approach, Philadelphia, PA: Saunders; 2011:232.